Stem Cells Technologies

We're an innovative, digitally oriented global stem cells technology company whose reach is rapidly expanding. Our mission is to bank cells and personalize medicine for customers around the globe.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

DIAGNOSTICS

AVANTOR® TO COLLABORATE WITH GEMINIBIO TO BRING CUSTOM HYDRATED SOLUTIONS AND CELL CULTURE MEDIA TO BIOPHARMA CUSTOMERS

Avantor | June 24, 2022

news image

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries has entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry. Custom hydrated solutions and cell culture media are critical components of the bioproduction workflow, especially for emerging modalities such as gene therapy. This c...

Read More

BIOCARE MEDICAL AND BETHYL LABORATORIES ANNOUNCES THE RELEASE OF A NEW RABBIT MONOCLONAL ANTIBODY FOR IMMUNOHISTOCHEMICAL APPLICATIONS

Biocare Medical | August 05, 2020

news image

Biocare Medical LLC, a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, in collaboration with Bethyl Laboratories announces the release of a new rabbit monoclonal antibody, TIGIT [BLR047F] antibody for in vitro diagnostic (IVD) use in the qualitative identification of the TIGIT protein by immunohistochemistry (IHC) in formalin-fixed paraffin-embedded (FFPE) human tissues.TIGIT plays an important role in transplantation tolerance and tumor i...

Read More

MEDTECH

FDA GRANTS ILIAD BIOTECHNOLOGIES FAST TRACK DESIGNATION FOR NEXT GENERATION PERTUSSIS VACCINE BPZE1

ILiAD Biotechnologies | January 04, 2022

news image

ILiAD Biotechnologies, a late stage biotech development company focused on global eradication of disease due to Bordetella pertussis, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BPZE1, a next generation vaccine for active booster immunization against pertussis. BPZE1 is the most advanced next generation pertussis vaccine currently in clinical development. Developed in the laboratory of Camille Locht, PhD, at the Institut Pasteur...

Read More

MEDTECH

SORRENTO ANNOUNCES COVISTIX COVID-19 VIRUS RAPID ANTIGEN DETECTION TEST DETECTS THE OMICRON VARIANT

Sorrento Therapeutics, Inc. | December 28, 2021

news image

Sorrento Therapeutics, Inc. announced that initial testing of COVISTIX on recombinant N proteins demonstrated its ability to detect the Omicron variant, in addition to detecting the original SARS-CoV-2 virus and its other major VoCs such as the delta and delta-plus strains. The COVISTIX detection levels were similar for all variants. The ease of use and timely detection of Omicron infection was demonstrated by a recent case report of a Mexico patient infected with the Omicron variant detected fi...

Read More
news image

DIAGNOSTICS

AVANTOR® TO COLLABORATE WITH GEMINIBIO TO BRING CUSTOM HYDRATED SOLUTIONS AND CELL CULTURE MEDIA TO BIOPHARMA CUSTOMERS

Avantor | June 24, 2022

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries has entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry. Custom hydrated solutions and cell culture media are critical components of the bioproduction workflow, especially for emerging modalities such as gene therapy. This c...

Read More
news image

BIOCARE MEDICAL AND BETHYL LABORATORIES ANNOUNCES THE RELEASE OF A NEW RABBIT MONOCLONAL ANTIBODY FOR IMMUNOHISTOCHEMICAL APPLICATIONS

Biocare Medical | August 05, 2020

Biocare Medical LLC, a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, in collaboration with Bethyl Laboratories announces the release of a new rabbit monoclonal antibody, TIGIT [BLR047F] antibody for in vitro diagnostic (IVD) use in the qualitative identification of the TIGIT protein by immunohistochemistry (IHC) in formalin-fixed paraffin-embedded (FFPE) human tissues.TIGIT plays an important role in transplantation tolerance and tumor i...

Read More
news image

MEDTECH

FDA GRANTS ILIAD BIOTECHNOLOGIES FAST TRACK DESIGNATION FOR NEXT GENERATION PERTUSSIS VACCINE BPZE1

ILiAD Biotechnologies | January 04, 2022

ILiAD Biotechnologies, a late stage biotech development company focused on global eradication of disease due to Bordetella pertussis, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BPZE1, a next generation vaccine for active booster immunization against pertussis. BPZE1 is the most advanced next generation pertussis vaccine currently in clinical development. Developed in the laboratory of Camille Locht, PhD, at the Institut Pasteur...

Read More
news image

MEDTECH

SORRENTO ANNOUNCES COVISTIX COVID-19 VIRUS RAPID ANTIGEN DETECTION TEST DETECTS THE OMICRON VARIANT

Sorrento Therapeutics, Inc. | December 28, 2021

Sorrento Therapeutics, Inc. announced that initial testing of COVISTIX on recombinant N proteins demonstrated its ability to detect the Omicron variant, in addition to detecting the original SARS-CoV-2 virus and its other major VoCs such as the delta and delta-plus strains. The COVISTIX detection levels were similar for all variants. The ease of use and timely detection of Omicron infection was demonstrated by a recent case report of a Mexico patient infected with the Omicron variant detected fi...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us